Related Experiment Video
Updated: Jun 10, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.6K
Activation of a Soft Robotic Left Ventricular Phantom Embedded in a Closed-Loop Cardiovascular Simulator: A
Nele Demeersseman1, Maria Rocchi2, Heleen Fehervary3,4
1Biomechanics Section, KU Leuven, Leuven, Belgium. nele.demeersseman@kuleuven.be.
Cardiovascular Engineering and Technology
|October 14, 2024
Summary
A novel soft robotic left ventricle simulator provides accurate preclinical testing for cardiovascular devices. This hybrid simulator validates a new method for regulating cardiac function, improving medical device reliability.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Robotics in Medicine
Background:
- Cardiovascular simulators are crucial for preclinical medical device testing.
- Increased realism in simulators enhances the reliability of preclinical results.
- Physiologically accurate simulation is key for advancing cardiovascular medical device development.
Purpose of the Study:
- To present a physiologically actuated soft robotic left ventricle (SRLV) within a hybrid cardiovascular simulator.
- To introduce and analyze a novel hydraulic pressure-based activation method for the SRLV.
- To computationally and experimentally validate the SRLV's performance in simulating cardiovascular conditions.
Main Methods:
- Developed a patient-specific SRLV phantom from CT scans using polyvinyl alcohol (PVA).
- Implemented a hybrid (in silico-in vitro) simulator integrating the SRLV.
- Utilized a finite element (FE) model for SRLV verification and a novel activation method to regulate left ventricular volume and pressure.
Main Results:
- The FE model and hybrid simulator accurately represented in silico data with deviations below 8.09% and 10%, respectively.
- The implemented activation method effectively regulated left ventricular volume and pressure.
- Experimental validation in the hybrid simulator confirmed the method's efficacy, with minimal deviations.
Conclusions:
- The developed activation method successfully represents diverse pressure-volume loops, validated both numerically and experimentally.
- This high-fidelity platform offers a robust foundation for testing cardiovascular medical devices under physiological conditions.
- The study advances the capability of cardiovascular simulators for more reliable preclinical assessments.

